Abstract
Pafuramidine is a novel orally active antimalarial. To identify a combination partner, we measured the in vitro antimalarial activities of the active metabolite, DB75, with amodiaquine, artemisinin, atovaquone, azithromycin, chloroquine, clindamycin, mefloquine, piperaquine, pyronaridine, tafenoquine, and tetracycline. None of the drugs tested demonstrated antagonistic or synergistic activity in combination with pafuramidine. Copyright © 2008, American Society for Microbiology. All Rights Reserved.
Cite
CITATION STYLE
Purfield, A. E., Tidwell, R. R., & Meshnick, S. R. (2008). Interactions of DB75, a novel antimalarial agent, with other antimalarial drugs in vitro. Antimicrobial Agents and Chemotherapy, 52(6), 2253–2255. https://doi.org/10.1128/AAC.01536-07
Register to see more suggestions
Mendeley helps you to discover research relevant for your work.